Skip to main content

Table 4 Multivariate logistic regression analysis of factors contributing to anti-JCV antibody positivity in patients with MS

From: Two susceptible HLA-DRB1 alleles for multiple sclerosis differentially regulate anti-JC virus antibody serostatus along with fingolimod

All participants (n = 128)

OR (95% CI)

p value

Age

1.06 (1.02–1.10)

0.006

HLA-DRB1*15

0.37 (0.16–0.90)

0.028

Sex (male)

1.59 (0.63–4.00)

0.321

Fingolimod usage at sampling

1.76 (0.52–5.89)

0.361

Lymphocyte count (× 1000/μL)

1.14 (0.47–2.79)

0.771

HLA-DRB1*04

0.92 (0.39–2.19)

0.850

  1. CI confidence interval, HLA human leukocyte antigen, JCV JC virus, MS multiple sclerosis, OR odds ratio